At Tactile Medical®, a fundamental value is to earn a fair profit and return value for our shareholders
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Q3 2021 Tactile Medical Earnings Conference Call
NOV 08 2021 5:00 PM EST
October 4, 2021
Tactile Medical to Release Third Quarter of Fiscal Year 2021 Financial Results on November 8, 2021
MINNEAPOLIS , Oct. 04, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of underserved chronic diseases at home, today announced that third quarter of fiscal year 2021
September 30, 2021
Tactile Medical Announces Enrollment of First Patient in Randomized, Controlled Clinical Trial Evaluating the Effectiveness of Flexitouch® Plus for the Treatment of Head and Neck Lymphedema
MINNEAPOLIS , Sept. 30, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the enrollment of the first patient in a
September 8, 2021
Tactile Medical Announces Acquisition of AffloVest®
Further expands the Company’s position as a leader in treating patients with underserved chronic conditions in the home Transaction aligns with Tactile Medical’s growth & margin goals, including 20%+ revenue growth, gross margins above 70% and expanding adjusted EBITDA margins MINNEAPOLIS , Sept.